company background image
V16 logo

Virbac DB:V16 Stock Report

Last Price

€379.50

Market Cap

€3.2b

7D

4.5%

1Y

43.2%

Updated

10 Oct, 2024

Data

Company Financials +

V16 Stock Overview

Manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East.

V16 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Virbac SA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Virbac
Historical stock prices
Current Share Price€379.50
52 Week High€392.00
52 Week Low€248.50
Beta0.95
11 Month Change5.42%
3 Month Change8.27%
1 Year Change43.21%
33 Year Change5.42%
5 Year Change64.64%
Change since IPO249.45%

Recent News & Updates

Recent updates

Shareholder Returns

V16DE PharmaceuticalsDE Market
7D4.5%-3.9%0.02%
1Y43.2%-15.4%11.7%

Return vs Industry: V16 exceeded the German Pharmaceuticals industry which returned -15.4% over the past year.

Return vs Market: V16 exceeded the German Market which returned 11.7% over the past year.

Price Volatility

Is V16's price volatile compared to industry and market?
V16 volatility
V16 Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.6%
10% least volatile stocks in DE Market2.4%

Stable Share Price: V16 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: V16's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19685,459Habib Ramdanicorporate.virbac.com

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners.

Virbac SA Fundamentals Summary

How do Virbac's earnings and revenue compare to its market cap?
V16 fundamental statistics
Market cap€3.22b
Earnings (TTM)€141.19m
Revenue (TTM)€1.34b

22.8x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
V16 income statement (TTM)
Revenue€1.34b
Cost of Revenue€446.54m
Gross Profit€892.83m
Other Expenses€751.63m
Earnings€141.19m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)16.86
Gross Margin66.66%
Net Profit Margin10.54%
Debt/Equity Ratio37.2%

How did V16 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

8%

Payout Ratio